US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ホーム
投資
株式
アメリカ
NYSE
NXG NextGen Infrastructure Income Fund (NXG) 銘柄情報

NXG NextGen Infrastructure Income Fund (NXG)

64.03

1.00

( 1.59% )

更新日時： 00:37:50

NXG NextGen Infrastructure Income Fund (NXG) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

64.03

( 1.59% )

買値

-

売値

-

出来高

61,312

62.50 日の範囲 64.1672

45.05 52 週間の範囲 65.7799

前日終値

63.03

始値

63.31

時刻

最終取引時間

00:37:50

平均取引量 (3 か月)

95,908

財務取引量

US$ 3,889,106

VWAP

63.4314

Form N-CEN/A - Annual Report for Registered Investment Companies: [Amend]

NXG NextGen Infrastructure Income Fund (NYSE: NXG) Announces 11.1% Distribution Increase

NXG NextGen Infrastructure Income Fund (NYSE: NXG) Announces 11.1% Distribution Increase PR Newswire DALLAS, June 2, 2026 DALLAS, June 2...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

NXG NextGen Infrastructure Income Fund (NYSE: NXG) Announces the Preliminary Results of its Rights Offering

NXG NextGen Infrastructure Income Fund (NYSE: NXG) Announces the Preliminary Results of its Rights Offering PR Newswire DALLAS, May 1, 2026...

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

Form 424B2 - Prospectus [Rule 424(b)(2)]

Form 497AD - Filing by certain investment companies of Rule 482 advertising [Rule 497 and 482(c)]

NXG NextGen Infrastructure Income Fund (NYSE: NXG) Announces Terms of Rights Offering

NXG NextGen Infrastructure Income Fund (NYSE: NXG) Announces Terms of Rights Offering PR Newswire DALLAS, March 26, 2026 DALLAS, March 26...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	4.03	6.71666666667	60	65.7799	59.68	226078	63.88268317	CS
4	4.18	6.98412698413	59.85	65.7799	57.0301	98828	61.10690522	CS
12	10.33	19.2364990689	53.7	65.7799	52.3001	95908	58.75258697	CS
26	12.98	25.4260528893	51.05	65.7799	49.75	74273	56.6092054	CS
52	14.24	28.6001205061	49.79	65.7799	45.05	62527	53.33882783	CS
156	25.75	67.2675026123	38.28	65.7799	30.32	41363	47.56487452	CS
260	61.05	2048.65771812	2.98	65.7799	2.98	25777	47.20119333	CS

NXG - Frequently Asked Questions (FAQ)

What is the current NXG NextGen Infrastructure Income Fund share price?

The current share price of NXG NextGen Infrastructure Income Fund is US$ 64.03

What is the 1 year trading range for NXG NextGen Infrastructure Income Fund share price?

NXG NextGen Infrastructure Income Fund has traded in the range of US$ 45.05 to US$ 65.7799 during the past year

RIGATONI

RIGATONI 2分前

.028 cleared ~Rig

ScottishTexan

ScottishTexan 4分前

So here's my question to you. When they dilute what happens to the share price? Does it go up or down? Sandbox would not have needed to dilute.

i_like_bb_stock

i_like_bb_stock 4分前

$CNEY china name know for big moves, been steady here think itll get found soon

i_like_bb_stock

i_like_bb_stock 4分前

$CNEY china name know for big moves, been steady here think itll get found soon

brazen22

brazen22 5分前

Maybe. But what matters more: preserving a journal publication, or getting MAA approval?

NWBO already has a JAMA paper. Does it need another journal article, or does it need MAA approval?

If the PSM/IPD analysis is important to approval, MHRA does not need to wait for a

linkvest

linkvest 6分前

MMs are surely trying to walk this down every time it hits around .11. They want in kept in their channel, whoever it is.

Whalatane

Whalatane 6分前

Tutes were buying Ernie . Gupta doesn't control the India based FDA inspectors .
Only thing he can do is raise some cash thru the ATM before June 29th , in case you know what hits the fan ...which he did .
JMO
Kiwi

joe botts

joe botts 7分前

joe botts

joe botts 7分前

It will be no bid Wed, next Wed etc etc

rosemountbomber

rosemountbomber 7分前

I often think back to the disconnect we had here when thinking about V in Europe. Most of us could not understand how analysts were modeling very little for the EU. In retrospect, they obviously knew better than most of us. No question a Euro-centric pharma would have been better at launching V i

US Market News

US Market News 8分前

PNC Raises Common Stock Dividend to $2.00 Per ShareJuly 6, 2026 11:32 AM
PR Newswire (US) class="legendSpanClass"PITTSBURGH, class="legendSpanClass"July 6, 2026 /PRNewswire/ -- The board of directors of The PNC Financial Services Group,

US Market News

US Market News 8分前

AI Energy Pivot Complete: LIXTE Biotechnology Finishes Corporate Rebrand to NOMAD Power Solutions, Begins Trading Under Nasdaq: NMADJuly 6, 2026 11:40 AM
PR Newswire (Canada) Issued on behalf of NOMAD Power Solutions, Inc. (Nasdaq: NMAD), formerly LIXTE

northam43

northam43 8分前

#1.1 SPX Cycles Daily Update. 60-S-2 (Overdue) confirmed during the 1ST hour. Next Possibilities: 60-2 (Extreme Overdue) 7530.79, 60-E-2 7623.60, 60-S-1 (Overdue) 7474.44, 60-1 7434.37. Possibility of D-2 (Extreme Overdue) today at the close, projected high 7560.87, high due today. Possibility o

US Market News

US Market News 8分前

AI Energy Pivot Complete: LIXTE Biotechnology Finishes Corporate Rebrand to NOMAD Power Solutions, Begins Trading Under Nasdaq: NMADJuly 6, 2026 11:40 AM
PR Newswire (Canada) Issued on behalf of NOMAD Power Solutions, Inc. (Nasdaq: NMAD), formerly LIXTE

US Market News

US Market News 8分前

AI Energy Pivot Complete: LIXTE Biotechnology Finishes Corporate Rebrand to NOMAD Power Solutions, Begins Trading Under Nasdaq: NMADJuly 6, 2026 11:40 AM
PR Newswire (Canada) Issued on behalf of NOMAD Power Solutions, Inc. (Nasdaq: NMAD), formerly LIXTE

SkyLimit2022

SkyLimit2022 8分前

HyGro,
“Journal's are not a regulator data source”
Fact ✅: Journals are a source that regulators consider all the time. Independently peer-reviewed medical literature is highly relevant & undeniably significant…

Regulatory agencies such as FDA & MHRA can & do conside

marylandstockguy

marylandstockguy 8分前

It’s always been strange to me how certain people can buy and sell at those numbers. Definitely seems wrong. Everyone should be in the same boat only getting to work with trips

kabunushi

kabunushi 8分前

In any case NWBO's achieving any real value depends on proof of commercial viability. I.e. MHRA approval. With that, the shares can seek a higher level. How high probably depends on seeing follow-on deal(s) and financing. Without it, NWBO is a merely research project and a failed attempt at commerci

Golden Cross

Golden Cross 8分前

$AABB Shareholder Update - Digital Asset & rGO Progress Report
https://www.youtube.com/watch?v=Rk4IC8tPrSI

https://www.youtube.com/watch?v=Rk4IC8tPrSI

Golden Cross

Golden Cross 9分前

$AABB Shareholder Update - Digital Asset & rGO Progress Report
https://www.youtube.com/watch?v=Rk4IC8tPrSI

https://www.youtube.com/watch?v=Rk4IC8tPrSI

DrHigh

investors allowed LP to hand pick her board which provides all the protection she needs. investors need to take the first step this year and stop reapproving them to the board including LP herself who needs our vote to reappoint.

northam43

northam43 9分前

#1.1 SPX Cycles Daily Update. 60-S-2 (Overdue) confirmed during the 1ST hour. Next Possibilities: 60-2 (Extreme Overdue) 7530.79, 60-E-2 7623.60, 60-S-1 (Overdue) 7474.44, 60-1 7434.37. Possibility of D-2 (Extreme Overdue) today at the close, projected high 7560.87, high due today. Possibility o

Whalatane

Whalatane 9分前

Good buying op. Story remains the same . OLC will likely be the best in class pho lowering med for dialysis patients .
Its just a question of timing .
Do the India based FDA inspectors get the inspection done in the next week or two and then the FDA issues a Class 1 resubmission ...o

BIOChecker4

BIOChecker4 9分前

Do whatever makes you happy. I’m fine with real science. I’ll keep getting COVID boosters and every other recommended vaccine. As for AVXL, the stock is down and no news. I was hoping for a PR on the Monday after the 4th of July weekend. Hopes and dreams.

NXG NextGen Infrastructu...

Tami Senior Securitisati...

Pacer US Large Cap Cash ...

Chongqing Rural Commerci... (PK)

Riverfort Global Opportu...

2.600% Rst Snr Nts 09/06...

Kermode Resources

Contineum Therapeutics

Barings Emerging EMEA Op...

5.280% Reset Nts 22/11/34

3.935% 12jul2047

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。